Contreras Rey María Beatriz, Arco Prados Yolanda, Sánchez Gómez Ernesto
Clinical Management Unit (CMU) of Pharmacy. Complejo Hospitalario Universitario de Huelva. Spain..
Farm Hosp. 2016 Jun 1;40(4):246-59. doi: 10.7399/fh.2016.40.4.10038.
To analyze the outcomes of a medication reconciliation process at admission in the hospital setting. To assess the role of the Pharmacist in detecting reconciliation errors and preventing any adverse events entailed.
A retrospective study was conducted to analyze the medication reconciliation activity during the previous six months. The study included those patients for whom an apparently not justified discrepancy was detected at admission, after comparing the hospital medication prescribed with the home treatment stated in their clinical hospital records. Those patients for whom the physician ordered the introduction of home medication without any specification were also considered. In order to conduct the reconciliation process, the Pharmacist prepared the best pharmacotherapeutical history possible, reviewing all available information about the medication the patient could be taking before admission, and completing the process with a clinical interview. The discrepancies requiring clarification were reported to the physician. It was considered that the reconciliation proposal had been accepted if the relevant modification was made in the next visit of the physician, or within 24-48 hours maximum; this case was then labeled as a reconciliation error. For the descriptive analysis, the Statistics® SPSS program, version 17.0, was used.
494 medications were reconciled in 220 patients, with a mean of 2.25 medications per patient. More than half of patients (59.5%) had some discrepancy that required clarification; the most frequent was the omission of a medication that the patient was taking before admission (86.2%), followed by an unjustified modification in dosing or way of administration (5.9%). In total, 312 discrepancies required clarification; out of these, 93 (29.8%) were accepted and considered as reconciliation errors, 126 (40%) were not accepted, and in 93 cases (29,8%) acceptance was not relevant due to a change in the situation of the patient. The highest opportunities for improvement were identified in the Gastroenterology, Internal Medicine and Surgery Units, and in the following therapeutic groups: blood and hematopoietic organs, cardiovascular system, and nervous system.
In our hospital, only a third of interventions were accepted and acknowledged as reconciliation errors. However, the medication reconciliation process conducted at admission by a Pharmacist has proven to be useful in order to identify and prevent medication errors. A better understanding of the cases in which interventions were not accepted could lead to an improvement in outcomes in the future.
分析医院入院时用药核对流程的结果。评估药剂师在检测核对错误及预防由此引发的不良事件中的作用。
开展一项回顾性研究,分析前六个月的用药核对活动。该研究纳入那些在入院时,经比较医院所开药物与临床病历中记录的家庭用药后发现明显不合理差异的患者。那些医生未作任何说明就要求引入家庭用药的患者也被纳入研究。为进行核对流程,药剂师尽可能整理出最佳的药物治疗史,查阅患者入院前可能服用的所有药物信息,并通过临床访谈完成该流程。需要澄清的差异会报告给医生。如果在医生下次查房时或最长在24至48小时内进行了相关修改,则认为核对建议已被接受;这种情况随后被标记为核对错误。对于描述性分析,使用了版本为17.0的Statistics® SPSS程序。
对220名患者的494种药物进行了核对,平均每位患者2.25种药物。超过一半的患者(59.5%)存在需要澄清的差异;最常见的是患者入院前服用的药物遗漏(86.2%),其次是剂量或给药方式的不合理修改(5.9%)。总共312处差异需要澄清;其中93处(29.8%)被接受并视为核对错误,126处(40%)未被接受,93例(29.8%)因患者情况变化而无需接受。在胃肠病科、内科和外科病房以及以下治疗组中发现了最大的改进机会:血液和造血器官、心血管系统以及神经系统。
在我们医院,只有三分之一的干预措施被接受并确认为核对错误。然而,药剂师在入院时进行的用药核对流程已证明有助于识别和预防用药错误。更好地理解未被接受的干预措施的情况可能会在未来改善结果。